XML 29 R6.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   48,051        
Beginning balance at Dec. 31, 2022 $ 1,031,569 $ 48 $ 1,325,524 $ (295,117) $ 1,370 $ (256)
Beginning balance (in shares) at Dec. 31, 2022           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   160        
Exercise of options to purchase common stock 4,517   4,517      
Vesting of restricted stock units (in shares)   66        
Vesting of restricted stock units (1,400)   (1,400)      
Share-based compensation expense 20,554   20,554      
Purchase of capped call options (66,211)   (66,211)      
Foreign currency translation (1,961)       (1,961)  
Net income (loss) (33,614)     (33,614)    
Ending balance (in shares) at Dec. 31, 2023   48,277        
Ending balance at Dec. 31, 2023 953,454 $ 48 1,282,984 (328,731) (591) $ (256)
Ending balance (in shares) at Dec. 31, 2023           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   352        
Exercise of options to purchase common stock 9,138 $ 1 9,137      
Vesting of restricted stock units (in shares)   87        
Vesting of restricted stock units (3,341)   (3,341)      
Share-based compensation expense 49,380   49,380      
Foreign currency translation (196)       (196)  
Net income (loss) $ 46,925     46,925    
Ending balance (in shares) at Dec. 31, 2024 48,702 48,716        
Ending balance at Dec. 31, 2024 $ 1,055,360 $ 49 1,338,160 (281,806) (787) $ (256)
Ending balance (in shares) at Dec. 31, 2024 14         14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   189        
Exercise of options to purchase common stock $ 2,106   2,106      
Vesting of restricted stock units (in shares)   80        
Vesting of restricted stock units (3,122)   (3,122)      
Share-based compensation expense 14,057   14,057      
Foreign currency translation 1,121       1,121  
Net income (loss) $ 139,137     139,137    
Ending balance (in shares) at Dec. 31, 2025 48,970 48,985        
Ending balance at Dec. 31, 2025 $ 1,208,659 $ 49 $ 1,351,201 $ (142,669) $ 334 $ (256)
Ending balance (in shares) at Dec. 31, 2025 14         14